Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Gut microbiota constituents may affect hypertrophic scarring risk through interaction with specific immune cells in a two-step, two-sample Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:40
  • Read more about Gut microbiota constituents may affect hypertrophic scarring risk through interaction with specific immune cells in a two-step, two-sample Mendelian randomization study

Genetic prediction of immune cells, inflammatory proteins, and metabolite-mediated association between gut microbiota and COPD: a Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:39
  • Read more about Genetic prediction of immune cells, inflammatory proteins, and metabolite-mediated association between gut microbiota and COPD: a Mendelian randomization study

Gut microbiota, plasma metabolites, and venous thromboembolism: a Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:38
  • Read more about Gut microbiota, plasma metabolites, and venous thromboembolism: a Mendelian randomization study

Unveiling the genetic association between rheumatoid arthritis and four common hand pathologies

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:33
  • Read more about Unveiling the genetic association between rheumatoid arthritis and four common hand pathologies

Identification of novel therapeutic targets for cognitive performance and associations with brain health

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:32
  • Read more about Identification of novel therapeutic targets for cognitive performance and associations with brain health

Endometriosis and Ovarian Cancer: Insights from NHANES and Mendelian Randomization Analysis

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:31
  • Read more about Endometriosis and Ovarian Cancer: Insights from NHANES and Mendelian Randomization Analysis

Metformin reduces the risk of frailty: evidence from a Mendelian randomization study

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:23
  • Read more about Metformin reduces the risk of frailty: evidence from a Mendelian randomization study

Identification of prostate cancer potential therapeutic targets and virtual drug screening through combined Mendelian randomization study, Bayesian colocalization and molecular docking

Submitted by Anna Hakala on Tue, 11/11/2025 - 08:14
  • Read more about Identification of prostate cancer potential therapeutic targets and virtual drug screening through combined Mendelian randomization study, Bayesian colocalization and molecular docking

Unveiling genetic and biological links: exploring the intersection of autoimmune and psychiatric disorders

Submitted by Anna Hakala on Thu, 11/06/2025 - 08:50
  • Read more about Unveiling genetic and biological links: exploring the intersection of autoimmune and psychiatric disorders

Associations of physical frailty and polygenic score with incident heart failure in cardiovascular patients: unraveling the mediating role of inflammation

Submitted by Anna Hakala on Thu, 11/06/2025 - 08:32
  • Read more about Associations of physical frailty and polygenic score with incident heart failure in cardiovascular patients: unraveling the mediating role of inflammation

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Current page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement